4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0000950170-24-130378
Director sold 4,891 shares at an average $41.08 ($200,947)
- Director gave up 1,695 shares (to pay taxes)
- Director acquired 6,586 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
PATOU GARY · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-22 | Exercise or conversion : show line 1 in the form | +3,500 | $7.38 | $25,830 | 27,073 | D |
| 2024-11-22 | Shares withheld for taxes : show line 2 in the form | −649 | $39.80 | $25,830 | 26,424 | D |
| 2024-11-22 | Sale : show line 3 in the form | −2,851 | $41.11 | $117,205 | 23,573 | D |
| 2024-11-22 | Exercise or conversion : show line 4 in the form | +3,086 | $13.48 | $41,599 | 26,659 | D |
| 2024-11-22 | Shares withheld for taxes : show line 5 in the form | −1,046 | $39.80 | $41,631 | 25,613 | D |
| 2024-11-22 | Sale : show line 6 in the form | −2,040 | $41.05 | $83,742 | 23,573 | D |
| Open-market sales · 4,891 sh · avg $41.08 · $200,947 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-22 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −3,500 | 0 | D |
| 2024-11-22 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −3,086 | 0 | D |
Loading xslF345X05/ownership.xml…